InvestorsHub Logo
Followers 135
Posts 13914
Boards Moderated 0
Alias Born 09/05/2013

Re: None

Tuesday, 04/07/2020 6:50:02 PM

Tuesday, April 07, 2020 6:50:02 PM

Post# of 23059
"Immune Responses Regulated by Cannabidiol":
27 Feb 2020

IL-6 is a proinflammatory cytokine produced by many cell types, predominantly innate cells. Many studies have shown that circulating IL-6 is readily inhibited by CBD in inflammatory models, including diabetes, asthma, pancreatitis, and hepatitis. CBD treatment in vivo resulted in lower IL-6 production in peritoneal macrophages stimulated ex vivo with LPS, in the pancreas in acute pancreatitis, and in bronchoalveolar lavage fluid in LPS-induced pulmonary inflammation.


Using peritoneal macrophages from diabetic mice stimulated ex vivo with LPS revealed that macrophages isolated from CBD-treated mice did not produce as much TNF-a or IL-6 as macrophages isolated from vehicle-treated mice.


A direct effect of CBD decreasing macrophage numbers in the bronchoalveolar lavage fluid was shown following intranasal LPS administration to induce pulmonary inflammation.


https://www.liebertpub.com/doi/10.1089/can.2018.0073

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.